Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.023
+0.003 (0.10%)
At close: Oct 7, 2025, 4:00 PM EDT
3.050
+0.027 (0.89%)
After-hours: Oct 7, 2025, 5:58 PM EDT
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $41.80 million as of October 7, 2025. Its market cap has increased by 48.30% in one year.
Market Cap
41.80M
Enterprise Value
21.76M
1-Year Change
48.30%
Ranking
Category
Stock Price
$3.02
Market Cap Chart
Since October 24, 2011, Grace Therapeutics's market cap has decreased from $87.20M to $41.80M, a decrease of -52.06%. That is a compound annual growth rate of -5.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 41.76M | 10.12% |
| Dec 31, 2024 | 37.92M | 39.61% |
| Dec 29, 2023 | 27.16M | 21.53% |
| Dec 30, 2022 | 22.35M | -59.95% |
| Dec 31, 2021 | 55.80M | 77.21% |
| Dec 31, 2020 | 31.49M | -84.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 761.07B |
| Johnson & Johnson | 456.91B |
| AbbVie | 410.16B |
| UnitedHealth Group | 325.39B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.14B |